{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T20:45:05Z","timestamp":1792183505369,"version":"4.4.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,4,15]],"date-time":"2019-04-15T00:00:00Z","timestamp":1555286400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiat Oncol"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13014-019-1271-7","type":"journal-article","created":{"date-parts":[[2019,4,16]],"date-time":"2019-04-16T11:03:07Z","timestamp":1555412587000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":69,"title":["DCE and DSC perfusion MRI diagnostic accuracy in the follow-up of primary and metastatic intra-axial brain tumors treated by radiosurgery with cyberknife"],"prefix":"10.1186","volume":"14","author":[{"given":"Rosa","family":"Morabito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Concetta","family":"Alafaci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Pergolizzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Pontoriero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Iati\u2019","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilla","family":"Bonanno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Gaeta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco Maria","family":"Salpietro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2716-5772","authenticated-orcid":false,"given":"Enricomaria","family":"Mormina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcello","family":"Longo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Granata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,4,15]]},"reference":[{"issue":"1","key":"1271_CR1","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/s13014-016-0702-y","volume":"11","author":"L Guo","year":"2016","unstructured":"Guo L, Wang G, Feng Y, Yu T, Guo Y, Bai X, Ye Z. Diffusion and perfusion weighted magnetic resonance imaging for tumor volume definition in radiotherapy of brain tumors. Radiat Oncol. 2016;11(1):123.","journal-title":"Radiat Oncol"},{"issue":"10","key":"1271_CR2","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/j.diii.2014.06.013","volume":"95","author":"A Raimbault","year":"2014","unstructured":"Raimbault A, Cazals X, Lauvin MA, Destrieux C, Chapet S, Cottier JP. Radionecrosis of malignant glioma and cerebral metastasis: a diagnostic challenge in MRI. Diagn Interv Imaging. 2014;95(10):985\u20131000.","journal-title":"Diagn Interv Imaging"},{"issue":"5","key":"1271_CR3","doi-asserted-by":"publisher","first-page":"877","DOI":"10.3174\/ajnr.A4218","volume":"36","author":"AJ Prager","year":"2015","unstructured":"Prager AJ, Martinez N, Beal K, Omuro A, Zhang Z, Young RJ. Diffusion and perfusion MRI to differentiate treatment related changes including pseudoprogression from recurrent tumors in high-grade gliomas with histopathologic evidence. AJNR Am J Neuroradiol. 2015;36(5):877\u201385.","journal-title":"AJNR Am J Neuroradiol"},{"issue":"1","key":"1271_CR4","doi-asserted-by":"publisher","first-page":"19","DOI":"10.2214\/AJR.11.7417","volume":"198","author":"GM Fatterpekar","year":"2012","unstructured":"Fatterpekar GM, Galheigo D, Narayana A, Johnson G, Knopp E. Treatment related change versus tumor recurrence in high-grade gliomas: a diagnostic conundrum--use of dynamic susceptibility contrast-enhanced (DSC) perfusion MRI. AJR Am J Roentgenol. 2012;198(1):19\u201326.","journal-title":"AJR Am J Roentgenol"},{"issue":"5","key":"1271_CR5","first-page":"901","volume":"21","author":"T Sugahara","year":"2000","unstructured":"Sugahara T, Korogi Y, Tomiguchi S, Shigematsu Y, Ikushima I, Kira T, et al. Posttherapeutic intraaxial brain tumor: the value of perfusion-sensitive contrast-enhanced MR imaging for differentiating tumor recurrence from nonneoplastic contrast-enhancing tissue. AJNR Am J Neuroradiol. 2000;21(5):901\u20139.","journal-title":"AJNR Am J Neuroradiol"},{"issue":"5","key":"1271_CR6","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1093\/neuonc\/nos307","volume":"15","author":"N Verma","year":"2013","unstructured":"Verma N, Cowperthwaite MC, Burnett MG, Markey MK. Differentiating tumor recurrence from treatment necrosis: a review of neuro-oncologic imaging strategies. Neuro-Oncology. 2013;15(5):515\u201334.","journal-title":"Neuro-Oncology"},{"issue":"5","key":"1271_CR7","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1148\/rg.325125002","volume":"32","author":"R Shah","year":"2012","unstructured":"Shah R, Vattoth S, Jacob R, Manzil FF, O'Malley JP, Borghei P, Patel BN, Cur\u00e9 JK. Radiation necrosis in the brain: imaging features and differentiation from tumor recurrence. Radiographics. 2012;32(5):1343\u201359.","journal-title":"Radiographics."},{"issue":"4","key":"1271_CR8","first-page":"996","volume":"77","author":"BJ Blonigen","year":"2010","unstructured":"Blonigen BJ, Steinmetz RD, Levin L, Lamba MA, Warnick RE, Breneman JC. Irradiated volume as a predictor of brain radionecrosis after linear accelerator stereotactic radiosurgery. Int J RadiatOncolBiol Phys. 2010;77(4):996\u20131001.","journal-title":"Int J RadiatOncolBiol Phys."},{"issue":"9","key":"1271_CR9","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1016\/0360-3016(80)90175-3","volume":"6","author":"GE Sheline","year":"1980","unstructured":"Sheline GE, Wara WM, Smith V. Therapeutic irradiation and brain injury. Int J Radiat Oncol Biol Phys. 1980;6(9):1215\u201328.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"1271_CR10","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s11060-006-9241-y","volume":"82","author":"MC Chamberline","year":"2007","unstructured":"Chamberline MC, Glantz MJ, Chalmers L, et al. Early necross following concurrent Temoal and radiotherapy in patients with glioblastoma. J Neuro-Oncol. 2007;82(1):81\u20133.","journal-title":"J Neuro-Oncol"},{"issue":"1","key":"1271_CR11","first-page":"75","volume":"53","author":"AW Lee","year":"2002","unstructured":"Lee AW, Kwong DL, Leung SF, Tung SY, Sze WM, Sham JS, et al. Factors affecting risk of symptomatic temporal lobe necrosis: significance of fractional dose and treatment time. Int J RadiatOncolBiol Phys. 2002;53(1):75\u201385.","journal-title":"Int J RadiatOncolBiol Phys"},{"issue":"2","key":"1271_CR12","first-page":"291","volume":"47","author":"E Shaw","year":"2000","unstructured":"Shaw E, Scott C, Souhami L, Dinapoli R, Kline R, Loeffler J, Farnan N. Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90-05. Int J RadiatOncolBiol Phys. 2000;47(2):291\u20138.","journal-title":"Int J RadiatOncolBiol Phys."},{"issue":"2","key":"1271_CR13","doi-asserted-by":"publisher","first-page":"367","DOI":"10.3174\/ajnr.A1362","volume":"30","author":"RF Barajas","year":"2009","unstructured":"Barajas RF, Chang JS, Sneed PK, Segal MR, McDermott MW, et al. Distinguishing recurrent intra-axial metastatic tumor from radiation necrosis following gamma knife radiosurgery using dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging. AJNR Am J Neuroradiol. 2009;30(2):367\u201372.","journal-title":"AJNR Am J Neuroradiol"},{"issue":"5","key":"1271_CR14","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1634\/theoncologist.9-5-528","volume":"9","author":"DJ Covarrubias","year":"2004","unstructured":"Covarrubias DJ, Rosen BR, Lev MH. Dynamic magnetic resonance perfusion imaging of brain tumors. Oncologist. 2004;9(5):528\u201337.","journal-title":"Oncologist."},{"issue":"6","key":"1271_CR15","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1002\/jmri.1880070622","volume":"7","author":"JD Hazle","year":"1997","unstructured":"Hazle JD, Jackson EF, Schomer DF, Leeds NE. Dynamic imaging of intracranial lesions using fast spin-echo imaging: differentiation of brain tumors and treatment effects. J MagnReson Imaging. 1997;7(6):1084\u201393.","journal-title":"J MagnReson Imaging"},{"issue":"1","key":"1271_CR16","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s11060-015-1893-z","volume":"125","author":"AA Thomas","year":"2015","unstructured":"Thomas AA, Arevalo-Perez J, Kaley T, Lyo J, Peck KK, et al. Dynamic contrast enhanced T1 MRI perfusion differentiates pseudoprogression from recurrent glioblastoma. J Neuro-Oncol. 2015;125(1):183\u201390.","journal-title":"J Neuro-Oncol"},{"issue":"2","key":"1271_CR17","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.semradonc.2010.11.001","volume":"21","author":"Y Cao","year":"2011","unstructured":"Cao Y. The promise of dynamic contrast-enhanced imaging in radiation therapy. Semin Radiat Oncol. 2011;21(2):147\u201356.","journal-title":"Semin Radiat Oncol."},{"issue":"11","key":"1271_CR18","doi-asserted-by":"publisher","first-page":"e6333","DOI":"10.1097\/MD.0000000000006333","volume":"96","author":"B Wan","year":"2017","unstructured":"Wan B, Wang S, Tu M, Wu B, Han P, Xu H. The diagnostic performance of perfusion MRI for differentiating glioma recurrence frompseudopreogression: a meta-analysis. Medicine (Baltimore). 2017;96(11):e6333.","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"1271_CR19","doi-asserted-by":"publisher","first-page":"24","DOI":"10.2214\/AJR.12.9543","volume":"200","author":"M Essig","year":"2013","unstructured":"Essig M, Shiroishi MS, Nguyen TB, Saake M, Provenzale JM, et al. Perfusion MRI: The five most frequently asked technical questions. AJR Am J Roentgenol. 2013;200(1):24\u201334.","journal-title":"AJR Am J Roentgenol"},{"issue":"11","key":"1271_CR20","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.3174\/ajnr.A4398","volume":"36","author":"TB Nguyen","year":"2015","unstructured":"Nguyen TB, Cron GO, Perdrizet K, Bezzina K, Torres CH, Chakraborty S, et al. Comparison of the diagnostic accuracy of DSC- and dynamic contrast-enhanced MRI in the preoperative grading of Astrocytomas. AJNR Am J Neuroradiol. 2015;36(11):2017\u201322.","journal-title":"AJNR Am J Neuroradiol"},{"issue":"2","key":"1271_CR21","doi-asserted-by":"publisher","first-page":"91","DOI":"10.2174\/157340507780619179","volume":"3","author":"TE Yankeelov","year":"2009","unstructured":"Yankeelov TE, Gore JC. Dynamic contrast enhanced magnetic resonance imaging in oncology: theory, data acquisition, analysis, and examples. Curr Med Imaging Rev. 2009;3(2):91\u2013107.","journal-title":"Curr Med Imaging Rev"},{"issue":"2","key":"1271_CR22","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/sj.bjc.6603515","volume":"96","author":"JP O'Connor","year":"2007","unstructured":"O'Connor JP, Jackson A, Parker GJ, Jayson GC. DCE-MRI biomarkers in the clinical evaluation of antiangiogenic and vascular disrupting agents. Br J Cancer. 2007;96(2):189\u201395.","journal-title":"Br J Cancer"},{"issue":"6","key":"1271_CR23","doi-asserted-by":"publisher","first-page":"E41","DOI":"10.3174\/ajnr.A4341","volume":"36","author":"K Welker","year":"2015","unstructured":"Welker K, Boxerman J, Kalnin A, Kaufmann T, Shiroishi M, Wintermark M. ASFNR recommendations for clinical performance of MR dynamic susceptibility contrast perfusion imaging of the brain. AJNR Am J Neuroradiol. 2015;36(6):E41\u201351.","journal-title":"AJNR Am J Neuroradiol"},{"issue":"5","key":"1271_CR24","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.acra.2011.01.018","volume":"18","author":"S Bisdas","year":"2011","unstructured":"Bisdas S, Naegele T, Ritz R, Dimostheni A, Pfannenberg C, Reimold M, Koh TS, Ernemann U. Distinguishing recurrent high-grade gliomas from radiation injury: a pilot study using dynamic contrast-enhanced MR imaging. Acad Radiol. 2011;18(5):575\u201383.","journal-title":"Acad Radiol"},{"issue":"9","key":"1271_CR25","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1093\/neuonc\/nor075","volume":"13","author":"J Narang","year":"2011","unstructured":"Narang J, Jain R, Arbab AS, Mikkelsen T, Scarpace L, Rosenblum ML, Hearshen D, Babajani-Feremi A. Differentiating treatment-induced necrosis from recurrent\/progressive brain tumor using nonmodel-based semiquantitative indices derived from dynamic contrast-enhanced T1-weighted MR perfusion. Neuro-Oncology. 2011;13(9):1037\u201346.","journal-title":"Neuro-Oncology"},{"issue":"5","key":"1271_CR26","first-page":"891","volume":"21","author":"HC Roberts","year":"2000","unstructured":"Roberts HC, Roberts TP, Brasch RC, Dillon WP. Quantitative measurement of microvascular permeability in human brain tumors achieved using dynamic contrast-enhanced MR imaging: correlation with histologic grade. AJNR Am J Neuroradiol. 2000;21(5):891\u20139.","journal-title":"AJNR Am J Neuroradiol"},{"issue":"2","key":"1271_CR27","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1148\/radiol.2532090007","volume":"253","author":"RF Barajas Jr","year":"2009","unstructured":"Barajas RF Jr, Chang JS, Segal MR, Parsa AT, McDermott MW, Berger MS, Cha S. Differentiation of recurrent glioblastoma multiforme from radiation necrosis after external beam radiation therapy with dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging. Radiology. 2009;253(2):486\u201396.","journal-title":"Radiology."},{"issue":"3","key":"1271_CR28","doi-asserted-by":"publisher","first-page":"552","DOI":"10.3174\/ajnr.A1377","volume":"30","author":"LS Hu","year":"2009","unstructured":"Hu LS, Baxter LC, Smith KA, Feuerstein BG, Karis JP, Eschbacher JM, et al. Relative cerebral blood volume values to differentiate high-grade glioma recurrence from posttreatment radiation effect: direct correlation between image-guided tissue histopathology and localized dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging measurements. AJNR Am J Neuroradiol. 2009;30(3):552\u20138.","journal-title":"AJNR Am J Neuroradiol"},{"issue":"6","key":"1271_CR29","doi-asserted-by":"publisher","first-page":"e264","DOI":"10.1016\/j.crad.2014.01.016","volume":"69","author":"K.E. Shin","year":"2014","unstructured":"Shin KE, Ahn KJ, Choi HS, Jung SL, Kim BS, Jeon SS, et al. DCE and DSC MR perfusion imaging in the differentiation of recurrent tumour from treatment-related changes in patients with glioma. Clin Radiol. 2014;9. \n                    https:\/\/doi.org\/10.1016\/j.crad.2014.01.016\n                    \n                  .","journal-title":"Clinical Radiology"}],"container-title":["Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-019-1271-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13014-019-1271-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-019-1271-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,13]],"date-time":"2020-04-13T23:18:20Z","timestamp":1586819900000},"score":1,"resource":{"primary":{"URL":"https:\/\/ro-journal.biomedcentral.com\/articles\/10.1186\/s13014-019-1271-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,15]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1271"],"URL":"https:\/\/doi.org\/10.1186\/s13014-019-1271-7","relation":{},"ISSN":["1748-717X"],"issn-type":[{"value":"1748-717X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,15]]},"assertion":[{"value":"13 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Each subject signed an informed consent before the examination. The entire study protocol was approved by our local Ethical Committee.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Each subject signed an informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"65"}}